Multicentre experience from tertiary skin cancer units on the role of sentinel lymph node biopsy in patients with pT1b melanoma
Clinical and Experimental Dermatology · 2024
DOI: 10.1093/ced/llad450 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical and Experimental Dermatology, 2024. Verfasst von Sam Hughes und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology. Hauptthemen laut MEDLINE: Melanoma, Sentinel Lymph Node Biopsy, Skin Neoplasms. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
Multicentre experience from tertiary skin cancer units on the role of sentinel lymph node biopsy in patients with pT1b melanoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology.
- St John's Institute of Dermatology, Guy's and St Thomas' Hospitals NHS Trust, London, UK.
- Department of Dermatology, Royal Free London NHS Foundation Trust, London, UK.
ORCID-Profile: Sam Hughes, Hareni Srenathan
Zitieren
APA
Hughes, S., Srenathan, H., Lynch, M., & Leeman, H. (2024). Multicentre experience from tertiary skin cancer units on the role of sentinel lymph node biopsy in patients with pT1b melanoma. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llad450
Vancouver
Hughes S, Srenathan H, Lynch M, Leeman H. Multicentre experience from tertiary skin cancer units on the role of sentinel lymph node biopsy in patients with pT1b melanoma. Clinical and Experimental Dermatology. 2024. doi:10.1093/ced/llad450
BibTeX
@article{Hughes2024,
author = {Hughes, Sam and Srenathan, Hareni and Lynch, Magnus and Leeman, Hayley},
title = {Multicentre experience from tertiary skin cancer units on the role of sentinel lymph node biopsy in patients with pT1b melanoma},
journal = {Clinical and Experimental Dermatology},
year = {2024},
doi = {10.1093/ced/llad450}
}
EUVIMED